Nonparametric estimation of asymptomatic duration from a randomized prospective cancer screening trial

Biometrics

Volumn 61, Issue 4, 2005, Pages 992-999

  Shen, Yu ^a   Huang, Xuelin ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Deconvolution; Interval censored; Nonparametric distribution; Randomized screening trials

Indexed keywords

DIAGNOSIS; DISEASE CONTROL;

CANCER SCREENING; CLINICAL DISEASE; DECONVOLUTIONS; INTERVAL CENSORED; NATURAL HISTORY; NON-PARAMETRIC ESTIMATIONS; NONPARAMETRIC DISTRIBUTION; PROSPECTIVES; RANDOMIZED SCREENING TRIAL; SCREENING STRATEGY;

DISEASES;

CANCER; DISEASE PREVALENCE; ESTIMATION METHOD; RESEARCH WORK;

ARTICLE; BREAST CANCER; CANCER SCREENING; CLINICAL PRACTICE; HUMAN; ONSET AGE; PROSPECTIVE STUDY; ADULT; BREAST TUMOR; CLINICAL TRIAL; COMPUTER SIMULATION; CONTROLLED CLINICAL TRIAL; FEMALE; MASS SCREENING; METHODOLOGY; MIDDLE AGED; MONTE CARLO METHOD; NONPARAMETRIC TEST; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGE OF ONSET; BREAST NEOPLASMS; COMPUTER SIMULATION; FEMALE; HUMANS; MASS SCREENING; MIDDLE AGED; MONTE CARLO METHOD; RANDOMIZED CONTROLLED TRIALS; STATISTICS, NONPARAMETRIC;

EID: 33644871902     PISSN: 0006341X     EISSN: 15410420     Source Type: Journal    
DOI: 10.1111/j.1541-0420.2005.00363.x     Document Type: Article

References (17)

1. Baker S. G. Kramer B. S., and Prorok P. C. ( 2002). Statistical issues in randomized trials of cancer screening. BMC Medical Research Methodology 2, 1 7.
2. Balasubramanian R. and Lagakos S. W. ( 2003). Estimation of a failure time distribution based on imperfect diagnostic tests. Biometrika 90, 171 182.
3. Cancer Surveillance Research Program, National Cancer Institute 1998). The Surveillance, Epidemiology, and End Results (SEER) Program. Available at http://www-seer.ims.nci.nih.gov.
4. Day N. E. and Walter S. ( 1984). Simplified models of screening for chronic disease: Estimation procedures from mass screening programmes. Biometrics 40, 1 13.
5. Etzioni R. and Shen Y. ( 1997). Estimating asymptomatic duration in cancer: The AIDS connection. Statistics in Medicine 16, 627 644.
6. Gentleman R. and Geyer C. J. ( 1994). Maximum likelihood for interval censored data: Consistency and computation. Biometrika 81, 618 623.
7. Klema V. C. and Laub A. J. ( 1980). The singular value decomposition: Its computation and some applications. IEEE Transactions on Automatic Control 25, 164 176.
8. Louis T. A. Albert A., and Heghinian S. ( 1978). Screening for the early detection of cancer III. Estimation of disease natural history. Mathematical Biosciences 40, 111 144.
9. Parmigiani G. and Skates S. ( 2001). Estimating distribution of age of the onset of detectable asymptomatic cancer. Mathematical and Computer Modelling 33, 1347 1360.
10. Pinsky P. F. ( 2001). Estimation and prediction for cancer screening models using deconvolution and smoothing. Biometrics 57, 389 395.
11. Shapiro S. Venet W. Strax P., and Venet L. ( 1988). Periodic Screening for Breast Cancer. The Health Insurance Plan Project and Its Sequelae, 1963-1986. Baltimore : Johns Hopkins University Press.
12. Shen Y. and Zelen M. ( 1999). Parametric estimation procedures for screening programmes: Stable and nonstable disease models for multimodality case finding. Biometrika 86, 503 515.
13. Straatman H. Peer P. G. M., and Verbeek A. L. M. ( 1997). Estimating lead time and sensitivity in a screening program without estimating the incidence in the screened group. Biometrics 53, 217 229.
14. Turnbull B. W. ( 1976). The empirical distribution function with arbitrarily grouped, censored and truncated data. Journal of the Royal Statistical Society, Series B 38, 290 295.
15. Vogel C. R. and Wade J. G. ( 1994). Iterative SVD-based methods for ill-posed problems. SIAM Journal on Scientific Computing 15, 736 754.
16. Zelen M. ( 1993). Optimal scheduling of examinations for the early detection of disease. Biometrika 80, 279 293.
17. Zelen M. and Feinleib M. ( 1969). On the theory of screening for chronic disease. Biometrika 56, 601 614.